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Bioreduction of a nitro group to an amine or a hydroxylamine is 
among the most attractive triggering reactions of antitumor 
prodrugs.[1,2] Prodrug 1, possessing a nitroarylmethyl group, can 
be enzymatically reduced to corresponding nitro anion radical 2 in 
living cells (Figure 1). However, anion radical 2 is usually oxidized 
by ROS (reactive oxygen species) to regenerate parent prodrug 1 
in aerobic non-malignant cells. On the contrary, the oxidation of 
nitro radical 2 is suppressed in hyopxic solid tumor, because 
concentration of molecular oxygen in hypoxic cells is lower than 
that in non-malignant cells. Therefore, radical anion 2 can be 
converted to cytotoxic drug 3 via further reduction followed by 
removal of the arylmethyl group specifically in tumor cells.[2] On 
the other hand, antibody-directed enzyme prodrug therapy 
(ADEPT) and gene-directed enzyme prodrug therapy (GDEPT) 
evoke a great clinical interest for cancer therapy, and they also 
utilize prodrugs with the nitroarylmethyl protective group.[2,3] For 
ADEPT or GDEPT, a bacterial nitroreductase is assembled on a 
tumor by conjugating to a tumor-specific antibody or is expressed 
in tumor cells by use of a tumor-specific gene vector to achieve a 
tumor-specific release of cytotoxin 3, respectively. With these in 
mind, we decided to develop an NO2 reduction-responsive amino 
acid that induces peptide bond cleavage after reduction of the 
nitro group, because it would potentially facilitate preparation of 
hypoxia-responsive peptidyl prodrugs and bioprobes. 
Figure 1. Reduction-responsive antitumor prodrug possessing nitroarylmethyl 
group. (Ar: aromatic ring; R = H or OH; X: heteroatom) 
Scheme 1. Stimulus-responsive peptide bond cleavage. (PG: protective group 
removable by a corresponding stimulus.) 
Previously, we reported a stimulus-responsive amino acid[4,5] 
and its application to controlling peptidyl function in living cells.[4] 
When peptide 4, possessing the stimulus-responsive amino acid, 
was exposed to a corresponding stimulus, removal of PG (a 
protective group removable by the stimulus) followed by 
lactonization of trimethyl lock moiety[6] induced peptide bond 
cleavage (Scheme 1). In the present paper, development of the 
reduction-responsive amino acid and its application to a hypoxia-
responsive peptide bond cleavage system are described. 
Because p-nitrobenzyl phenyl ether is known to be split under 
hypoxic conditions via reduction of the nitro group,[7] it was used 
as the PG group. Fmoc protected reduction-responsive amino 
acid 8, possessing the p-nitrobenzyl group, was synthesized as 
shown in Scheme 2. Phenol 5[8] was treated with p-nitrobenzyl 
bromide in the presence of K2CO3 to afford ether 6. The TBS 
group of 6 was then removed under acidic conditions. After two-
step oxidation of generated alcohol 7, the Boc group was 
replaced with an Fmoc group to give reduction-responsive amino 
acid derivative 8. The amino acid derivative was then 
incorporated into model peptide 9 using Fmoc solid phase 
peptide synthesis (Fmoc SPPS) to demonstrate a capability to 
induce the reduction-responsive peptide bond cleavage. 
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Scheme 2. Reagents and conditions. a) p-Nitrobenzyl bromide, K2CO3, DMF, 
99%; b) AcOH aq., THF, quant.; c) PDC, DMF; d) NaClO2, 2-methyl-2-butene, 
NaH2PO4, acetone, H2O; e) HCl, AcOEt; f) FmocOSu, Na2CO3 aq., MeCN, 97% 
(4 steps); g) Fmoc SPPS. (A: alanine; D: aspartic acid; G: glycine; Q: glutamine; 
R: arginine; S: serine; Y: tyrosine). 
To examine whether a reduction of the nitro group triggers the 
peptide bond cleavage, chemical reduction of peptide 9 was 
performed as shown in Scheme 3. To peptide 9 in aqueous 
solution of NH4Cl was added a zinc powder under slightly acidic 
conditions, and the reaction mixture was incubated at 37 °C. 
During the reaction and HPLC purification under acidic conditions, 
removal of the p-aminobenzyl group of 10 was not observed. The 
obtained aniline 10 was incubated under physiological conditions 
(pH 7.4 of phosphate buffer, 37 °C). The reaction progress was 
monitored by HPLC, and the peptides were characterized by ESI-
MS (Figure 2A). After 24 h of incubation, peptide 10 was 
completely converted to corresponding peptide fragments 12 and 
13. Intermediate 11 was not observed during the reaction; 
therefore, we concluded that the rate determining step was the 
removal of the p-aminobenzyl group. The disappearance of 
peptide 10 showed first-order dependence on the concentration 
of starting material 10, and the half-life was determined as 3.1 h 
(Figure 2B). Because many tumor regions are known to be 
slightly acidic,[1] the half-life at pH 6.0 was also estimated, and 
was quite similar to that at pH 7.4 (t1/2 = 3.7 h at pH 6.0). 
 
Scheme 3. Reagents and conditions. a) Zn, NH4Cl aq., 37 °C; b) Sodium 
phosphate buffer (pH 7.4 or 6.0, 20 mM), 37 °C. 
 
## Figure 2, see page 3 ## 
Next, we designed FRET (Fluorescence Resonance Energy 
Transfer)-based peptide 14 to demonstrate the capability of the 
reduction-responsive amino acid to induce peptide bond cleavage 
in living hypoxic cells (Scheme 4). Peptide 14 possesses a dabsyl 
group as a quencher, a fluoresceinyl group as a fluorophore,[9] 
and an octaarginine as a cell-penetrating peptide sequence.[10] 
Once added to a cell, peptide 14 should penetrate into the cell, 
but it does not show fluorescence because of quenching by FRET. 
Upon the peptide bond cleavage, strong fluorescence of 
generated peptide fragment 15 can be observed. Peptide 14 and 
reference peptide 16, possessing a tyrosine residue instead of 
the reduction-responsive amino acid, were synthesized using 
Fmoc SPPS (details are shown in Supporting Information). The 
peptide was incubated with Caco-2 cells under hypoxic (1% (v/v) 
O2 and 5% (v/v) CO2 in N2) or aerobic (5% (v/v) CO2 in air) 
conditions for 15 h, respectively. After exchanging medium 
followed by fluorescence microphotography, fluorescence 
intensity per cell area was calculated based on the fluorescence 
image. As shown in Figure 3, strong fluorescence was observed 
only when the cells were treated with peptide 14 under hypoxic 
conditions. Therefore, it was demonstrated that the reduction-
responsive amino acid can induce the hypoxia-responsive 
peptide bond cleavage in living cells. 
 
## Scheme 4, see page 4 ## 
 
 
Figure 3. Visualization of peptide bond cleavage in living cells. Caco-2 cells 
were incubated with 300 nM peptide 14 or 16 under hypoxic (1% (v/v) O2 and 
5% (v/v) CO2 in N2) or aerobic (5% (v/v) CO2 in air) conditions for 15 h. A) 
Microscopic images after exchanging medium. FTC: Fluorescence images at 
λex = 460-490 nm and λem = 510 nm; B) Quantitative analysis of the 
fluorescence images. Fluorescence/cell area was average of 4 runs (10 
cells/run), and statistical analyses were performed using Dunnett’s test 
(*p<0.001). Error bars are + s.d. 
In conclusion, we developed a reduction-responsive amino 
acid that induced peptide bond cleavage after reduction of a nitro 
group, and the cleavage products were obtained in high purity. 
Kinetic study of the peptide bond cleavage revealed that the half-
life of peptide 10 at pH 6.0 was similar to that at pH 7.4. This 
suggests that the reduction-responsive amino acid could function 
even in acidic cancer cells. The capability of the reduction-
responsive amino acid to induce hypoxia-responsive peptide 
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bond cleavage in living cells was then examined. Cell-based 
assay clarified that the peptide bond cleavage was efficiently 
induced only in the hypoxic cells. We believe that these results 
represent an indispensable step toward the development of 
hypoxia-responsive peptidyl prodrugs and bioprobes. Application 
of the reduction-responsive amino acid to a hypoxia-responsive 
antitumor prodrug is in progress. 
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Figure 2. Reaction monitoring of the peptide bond cleavage of aniline 10 as shown in Scheme 3; A) HPLC profile of the peptide bond cleavage reaction. Analytical 
HPLC conditions: linear gradient of 0.1% (v/v) TFA/MeCN in 0.1% (v/v) TFA aq., 1-50% over 30 min; B) First order kinetic treatment of the data. Percentage of 
remaining substrate 10 was estimated based on HPLC peak area. Error bars are ± s.d. 
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Scheme 4. Design of FRET-based hypoxia-responsive peptide 14 and reference peptide 16. (G: glycine; K: lysine; R: arginine) 
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of hypoxic tumor-specific peptidyl prodrugs. Bioreduction of a nitro group is among 
the most attractive triggering reactions in the hypoxia-responsive prodrugs. In this 
paper, design and synthesis of a reduction-responsive amino acid that induces 
peptide bond cleavage after reduction of the nitro group are described. Application 
to hypoxia-responsive peptide bond cleavage system is also reported. 
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